Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
January 04, 2023
Attending 41st Annual J.P.Morgan Healthcare Conference
Manoj Vyas (CEO – CBCC Global Research) will be attending The 41st Annual J.P.Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, during 9 – 12 January 2023, at San Francisco, CA.
For more information about this conference, please visit: https://lnkd.in/gkACrmv
For business appointments please email us at bd@cbcc.global
Submit RFP to CBCC Global Research for your clinical program(s):
https://lnkd.in/dGEP2wy3